Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
===============================================================================================================================================================================================================================

* Firas Hamdan
* Erkko Ylösmäki
* Jacopo Chiaro
* Yvonne Giannoula
* Maeve Long
* Manlio Fusciello
* Sara Feola
* Beatriz Martins
* Michaela Feodoroff
* Gabriella Antignani
* Salvatore Russo
* Otto Kari
* Moon Hee Lee
* Petrus Järvinen
* Harry Nisen
* Anna Kreutzman
* Jeanette Leusen
* Satu Mustjoki
* Thomas G McWilliams
* Mikaela Grönholm
* Vincenzo Cerullo